TIME 100 ’s Giuliano Testa: We Should Think About Infertility As a ‘Wellbeing Issue’
Dr. Giuliano Testa, a transplant surgeon at Baylor University Medical Center at Dallas who led the medical team that performed the first successful uterus transplants in the United States, said Tuesday that he hopes “what we are doing is going to shed light on infertility for women.” “I personally never knew it was such a widespread issue,” Testa said at the TIME 100 Gala on Tuesday. “We should be thinking about it not just as a birth, but a wellbeing issue.” Testa attended the TIME 100 Gala after being named by TIME magazine as one of the most influential people in the world for his role in helping women give birth via uterus transplant. MORE: The 100 Most Influential People of 2018 Women who participate in Testa’s trial have absolute uterine factor infertility (AUI), which means their uterus is nonfunctioning or nonexistent. Most of the women have a condition called Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, which means they were born without a uterus and lived their entire lives under the assumption that they would never be able to be pregnant or give birth to a baby. The procedure can also work for women with other medical issues, such as certain cancers. MORE: First U.S. Baby Born After a Uterus Transplant In a tribute to Testa for the 2018 TIME 100, the first woman who gave birth to a baby via uterus transplant (and who wishes to remain anonymous) recalled giving birth to a healthy baby boy in November. “As I h...
We report two cases in which fecal microbiota transplantation used for the treatment of recurrent Clostridium difficile infection were effective in eradicating colonization by carbapenemase-producing Enterobacteriaceae. The presented cases illustrate the potential benefit of fecal microbiota transplantation in resolution of asymptomatic carrier states of multiresistant microorganisms, suggesting the need for further investigations with a view to their applicability in this area.
Officially it ’s a ‘unique holiday hotel for cancer patients and those with life-threatening illnesses’, according to the sign outside the Twenties green-shuttered building in Bournemouth.
Sarah Brookes, 41, a mother of two from Bradford, West Yorkshire, would like commercial sunbeds to be banned outright.
ConclusionsIn a setting of short waiting list times, IABP can be used to bridge candidates to urgent HT with acceptable postoperative results, but there were significant rates of adverse clinical events during support.ResumenIntroducción y objetivosEn España, el balón de contrapulsación intraaórtico (BCIA) se ha usado frecuentemente como puente al trasplante cardiaco (TxC) urgente. El propósito es analizar los resultados de esta estrategia.MétodosSe realizó una revisión retrospectiva caso por caso de los registros clínicos de 281 pacientes adultos listad...
Publication date: August 2018Source: Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Volume 1870, Issue 1Author(s): Chi Van Dang
Publication date: August 2018Source: Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Volume 1870, Issue 1Author(s):
The steep increase in thyroid cancer diagnosis has not been mirrored by increasing mortality rates and is likely due to widespread overdiagnosis of small neoplasms.
The presence of HER3 expression and a high HER2/CEP17 ratio distinguish a group of invasive HER2-positive ductal breast cancer patients who have a worse prognosis.
Publication date: 13 August 2018Source: Cancer Cell, Volume 34, Issue 2Author(s): Manisha Rao, Scott PowersIn this issue of Cancer Cell, Menghi et al. show that tandem duplications (TDs) are a common genetic feature of gynecological and triple-negative breast cancers. They also provide evidence that these TDs generate genetic alterations driving these cancers, which, if substantiated, will fundamentally change our understanding of their oncogenesis.
Publication date: 13 August 2018Source: Cancer Cell, Volume 34, Issue 2Author(s): Carolyn Hurst, Jonathan Rosenberg, Margaret KnowlesBladder cancers, the majority of which are urothelial carcinoma, are the most common urinary tract cancers. There are two major disease types, muscle-invasive and non-muscle-invasive, with distinct pathogenesis pathways, molecular features, and clinical outcomes. Recent genomic and transcriptomic data have significantly improved tumor sub-classification and prognostication for both patient groups and are informing improved approaches to treatment of muscle-invasive disease. To view this SnapS...